image credit: Pxfuel

Prime Therapeutics launches PreserveRx(SM) gene therapy financial protection

April 6, 2020

Via: BioSpace

Prime Therapeutics LLC (Prime), together with BCS Insurance Company, today released its latest product, PreserveRxSM, the most robust gene therapy reinsurance solution in the market to date. PreserveRx seeks to protect both health plans and employers from sudden, one-time costs due to covering ultra-expensive gene therapies, while preserving access to these potentially life-changing or curative gene therapies for members. This clinical and financial solution is specifically designed to reinsure high-cost gene therapies for payers that cover these gene therapies and help preserve member access and coverage for these life-altering therapies.

Read More on BioSpace